Noesion Radarnoesion.ai
Regulation2026-10-30

FDA and CMS officials are working to prevent a regulatory conflict. States and the federal government both oversee clinical AI. States regulate medical practice and clinician licensing. AI performing clinical tasks without supervision may fall under FDA device rules. The Trump administration eased regulatory burdens for health AI developers. Confusion over jurisdiction could stall AI adoption in health care. Officials are addressing the issue behind the scenes.

What changed

States and the federal government had overlapping jurisdiction over clinical AI without coordination.

What it unlocks

Avoiding regulatory conflicts that could stall health AI adoption in clinical settings.

Sources

Send this to someone who needs it

Shares the story and its sources. Nothing about you.

What does this mean for your job?

This is the story as everyone gets it. Once a week we send you the version written for your role — what changed, why it matters for the work you actually do, and one thing to try. Free while we tune it.